Key result
AI-ECG myocardial disease grades linked to ~52% higher mortality in significant mitral annular calcification.
Why the study?
Whether a validated AI-ECG model for left ventricular diastolic function can provide prognostic risk stratification in patients with significant mitral annulus calcification was evaluated.
Does myocardial disease grading derived from an AI-ECG left ventricular diastolic function model stratify all-cause mortality risk in patients with significant mitral annulus calcification?
Cohort (n=2,506)
Does myocardial disease grading derived from an AI-ECG left ventricular diastolic function model stratify all-cause mortality risk in patients with significant mitral annulus calcification?
AI-ECG-derived left ventricular diastolic function grading independently predicts all-cause mortality in patients with significant mitral annulus calcification, offering a tool to identify high-risk individuals.
May aid mortality risk stratification in mitral annulus calcification; extends AI-ECG diastolic validation but leaves open clinical adoption.
To evaluate whether a validated artificial intelligence-enabled electrocardiography (AI-ECG) model for left ventricular diastolic function (LVDF) can provide prognostic risk stratification in patients with significant mitral annulus calcification (MAC). We included patients who underwent transthoracic echocardiography and electrocardiography within 1 week between September 1, 2001, and April 30, 2023, and were not included in the AI-ECG LVDF training data set. Significant MAC was defined by consensus echocardiography criteria. Patients were assigned to 3 myocardial disease (MD) categories by the AI-ECG LVDF algorithm grading: normal/grade 1 LVDF (MD-1), grade 2 LVDF (MD-2), and grade 3 LVDF (MD-3). The analysis focused on prognostic stratification in this clinically distinct population. The primary end point was all-cause mortality. Of 2506 patients with significant MAC (mean age, 77 years; 64.1% female), 709 (28.3%) were classified as MD-1, 1510 (60.3%) as MD-2, and 287 (11.5%) as MD-3. Advanced MD grade correlated with older age, male sex, lower left ventricular ejection fraction, higher rates of comorbidities, and worse LVDF echocardiographic parameters. During a median follow-up of 2.8 years, 1059 (42.3%) patients died. Multivariable survival analysis found MD-2 (adjusted hazard ratio, 1.40; 95% CI, 1.19 to 1.64) and MD-3 (adjusted hazard ratio, 1.52; 95% CI, 1.21 to 1.92) to be independently associated with higher mortality risk, also after adjustment for mitral inflow diastolic pressure gradients. Myocardial disease grading derived from AI-ECG LVDF is independently associated with increased mortality risk in patients with significant MAC, underscoring its potential value in identifying high-risk patients in this challenging clinical population.
No takes yet. Share an insight, caveat, or question.
Tsaban et al. (2026) conducted a cohort in Significant mitral annulus calcification (MAC) (n=2,506). AI-ECG LVDF myocardial disease grade 3 (MD-3) and grade 2 (MD-2) vs. Normal/grade 1 LVDF (MD-1) was evaluated on All-cause mortality (HR 1.52 (MD-3 vs MD-1); HR 1.40 (MD-2 vs MD-1), 95% CI 1.21-1.92). AI-ECG-derived myocardial disease grades MD-2 (aHR 1.40; 95% CI 1.19-1.64) and MD-3 (aHR 1.52; 95% CI 1.21-1.92) were independently associated with higher mortality in significant MAC.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: